H.R. 7828: PRICED Act
Before you vote › Federal bills
H.R. 7828: PRICED Act
117th Congress · introduced 2022-05-18 · Health · Latest: Referred to the House Committee on Energy and Commerce.
federal
Follow this bill, step by step
- Where it came from: introduced 2022-05-18 · official record
- Who proposed it: Rep. Schakowsky, Janice D. [D-IL-9] · what a sponsor is
- What happened next: no floor votes in our records yet. Why?
- Where it stands now: Referred to the House Committee on Energy and Commerce. Not final yet: this can still change. We check for updates every day.
- If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.
Official title
PRICED Act
Plain summary
Price Relief, Innovation, and Competition for Essential Drugs Act or the PRICED Act This bill allows biosimilars to be marketed five years after the reference brand-name biological product is licensed. Currently, brand-name biological products are provided a 12-year marketing-exclusivity period. This shortened marketing-exclusivity period applies only to biological products licensed by the Food and Drug Administration after enactment of this bill.
Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.
What a vote does
A “Yea” vote
If it passes both chambers and is signed, it becomes law.
A “Nay” vote
If it is not passed, current law stays as it is.
PSI Sci description of the legislative step (not an opinion).
What does this mean? (plain words)
AI explanation – may be wrong, check the official text
No AI explanation yet. It takes up to a minute to write and is then saved for everyone.
Limited to a few requests an hour per person.
The strongest published arguments
Arguments for (supporters)
Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.
Arguments against (opponents)
Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.
Alternatives
Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.
How did my representative vote? · This bill's floor votes
Officials and money
Sponsor: Rep. Schakowsky, Janice D. [D-IL-9] · 10 cosponsors
Cost estimate: No cost estimate published yet.
Cosponsors on this site
Bruce Westerman (R-AR), Ro Khanna (D-CA), Lloyd Doggett (D-TX), Mark Pocan (D-WI), Marcy Kaptur (D-OH), Jesús G. "Chuy" García (D-IL), Rosa L. DeLauro (D-CT), Raja Krishnamoorthi (D-IL), Pramila Jayapal (D-WA)
Sponsor's campaign money: Rep. Schakowsky, Janice D. [D-IL-9] reported raising $415,385 (2025–2026). Details. Shown for context only; it does not mean any donor supported this bill.
No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.
Words on this page, explained (1)
- Bill
- A proposed law. It becomes law only if it passes the legislature and is signed by the president or governor (or a veto is overridden).
Plain meanings written from linked sources. All words.
Sources
- Congressional Research Service summary (Introduced in House)
- Congress.gov
- Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-117hr7828.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/117/hr>
Record fed-us-cong117-hr7828 · catalog fed-us-congress-bills-cong117 · updated 2026-11-15 by psicol fed-bills-cong117